Astrazenica is a vaccine play that is holding its golden pocket low at the .618 ratio. These setups are strong possibility for an uptrend in the future.
We're looking at a stop-loss underneath the latest low that gives a strong risk-to-reward scenario for Astrazenica moving forward. As more vaccine's are set to deploy, we think Astrazenica can capitalize.